ALKBH5 and glioblastoma: Despite demonstrating ALKBH5's pro-angiogenesis role in GBM and establishing that down-regulation of ALKBH5 in GBM substantially reduces both in vitro and in vivo VEGFA expression and secretion, there remain several limitations that must be addressed.